ARGX
Argenx SE
$877.62
-31.87 (-3.50%)
At close · Jul 10
Market Cap
$54.85B
Shares
62,187,771
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$877.62
Open$904.79
Day$868.55–904.79
52W$549.85–953.58
Avg vol 30d349K
Short int1.5M · 2.3% float · 3.5d
Short vol77%
Last earningsDec 31, 2025
DataJan 2020–Jul 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
Moderate
Market backdrop
VIX 15 · calm
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+7%
above
Price vs 50-day avg
+3%
above
RSI (14)
49
neutral
MACD trend
Negative
52-week position
81%
mid-range
Momentum
relative strength
1-month return
+2%
trailing
6-month return
+8%
trailing
YTD return
+4%
this year
Relative strength
−1%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $848 › 200d $822 — 50d above 200d
Institutional flow
Distributing
20 of 478 funds reported for Jun 30 · net -916 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.33% of float · ▼ -1.1% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
478 holders — mid 3-yr range
Squeeze score
54
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
32%
annualized · 1-yr
Max drawdown
−29%
past year
ATR
3.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+7%
Bullish
Price vs 50-day avg
+3%
Bullish
RSI (14)
49
Neutral
MACD trend
Negative
Bearish
52-week position
81%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $848 › 200d $822 — 50d above 200d
Institutional flow
Distributing
20 of 478 funds reported for Jun 30 · net -916 sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
2.33% of float · ▼ -1.1% MoM · 3.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
478 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $550
Now $878 · 81%
52-wk high $954
vs 200-day avg +7%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ARGX
this stock
Argenx SE
|
$54.85B | +4.4% | — | — | 2.3% |
|
ONC
BeOne Medicines Ltd.
|
$431.70B | -1.7% | +22179.2% | 878.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$123.19B | +7.1% | +46.2% | 28.8 | 1.9% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.67B | -13.8% | +20.8% | 16.2 | 3.3% |
|
CSLLY
Csl Ltd
|
$41.40B | -24.0% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ARGX | -6.6% | +1.8% | +7.9% | -5.4% | +4.4% |
| SPY | +1.4% | +4.1% | +9.1% | +1.1% | +10.7% |
| vs SPY | -8.0% | -2.3% | -1.1% | -6.5% | -6.4% |